Bionano Genomics Inc (BNGO.xnas)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Bionano Genomics Inc (BNGO.xnas) Profile

Bionano Genomics Inc (BNGO.xnas) is a genome analysis company providing Saphyr platform with tools and services to analyse the long segments of genomic DNA headquartered in California, America. Bionano company does extensive genetic research, patient testing, and diagnosing testing for autism spectrum disorder and other neurodevelopmental disabilities and offers proprietary nanochannel chips and automated imaging instrument. Bionano’s platform Saphyr provides ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and streamline the study of chromosome changes. Bionano Genomics employs 180 people and has a market capitalisation of $1.05B (USD) as of December 2021. The Bionano Genomics Inc stock (BNGO.xnas) is listed on NASDAQ and has a $4.7M (USD) in 2021 revenue. The Bionano is the parent company of BioDiscovery and Lineagen and has 3 offices in 3 countries. Bionano Genomics Inc is making major improvements with the Saphyr platform, with a record number of Saphyr shipments and saw a big increase of 122% year-over-year in the sale of nanochannel array flow cells used with the instrument. The company released Bionano Solve version 3.7 and Bionano Access version 1.7 as available data solution upgrades for Saphyr systems installed in laboratories worldwide and as of November 2021.

Holding cost
Trading hours in US Eastern Time

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade Bionano Genomics Inc (BNGO.xnas) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

Bắt Đầu Giao Dịch sau một vài phút

bullet Truy cập trên 10.000 công cụ tài chính
bullet Tự động mở & đóng vị thế
bullet Lịch sự kiện tin tức & kinh tế
bullet Chỉ báo & biểu đồ kỹ thuật
bullet Bao gồm nhiều công cụ hơn

Bằng việc cung cấp email của mình, bạn đồng ý với chính sách về quyền riêng tư của FP Markets và nhận các tài liệu marketing trong tương lai từ FP Markets. Bạn có thể hủy đăng ký bất cứ lúc nào.

Source - cache | Page ID - 16954

Get instant Updates in Telegram